<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210227050516N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-04-11</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of breast milk odor on respiratory distress  and oxygen saturation of preterm infants in intensive care unit</public_title>
      <acronym></acronym>
      <scientific_title>The effect of breast milk odor on respiratory distress  and oxygen saturation of preterm infants in intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-03-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>96</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54676</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, first, individuals are entered into the study in an accessible manner based on inclusion and exclusion criteria, and then, using permutation blocks, they are divided into two groups: breast milk odor and formula milk odor (32 people in each group) and will be allocated. In this method, if we consider the odor group of breast milk as A, the odor group of formula as B, the 6 possible states will be in the four blocks of AABB-BBAA-ABAB-BABA-BAAB-ABBA, which is assigned a number to each block. Will be found and each time a lottery will be selected and the babies will enter the study in order, Blinding description: The study will be blinded in two ways. Parents of infants and ward nurses will be blinded as to which group (control or intervention) they are in (unaware of the assignment of study groups) and the statistician who should analyze the data will be blinded to the type of intervention.In the analysis form, the intervention and control groups are identified by a specific code that only the researcher is aware of, and the statistical consultant does not know the definition of the codes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>respiratory distress.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: Infants who are exposed to the smell of breast milk. 3 cc of milk is taken daily from mothers to perform research; Sampling is done in the morning before breakfast to reduce the effect of odor on the milk in the mother's diet; Because the smell of food is secreted in milk 2-4 hours after consumption. Milk is stored in special plastic containers in the refrigerator. It is worth mentioning that breast milk will be used twice a day; ; Once at 8 o'clock in the morning and the next time at 12 noon, considering that the milk will be taken from the mothers only in the morning, the milk should be kept in the refrigerator for the evening shift. Prior to the intervention, the breast milk will be heated to 37 ° C by a water heater (Ben Marie). Intervention 2: Intervention group2:To prepare formula milk as a placebo (placebo group), use dry milk for premature babies with the Bebelac brand in the section, which was prepared just before use. Prior to the intervention, the formula milk (to body temperature) will be heated to 37 ° C by a water heater (Ben Marie). Intervention 3: Control group: Does not receive any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Akram Sadat Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tohid Square - Nosrat Sharghi St. - Faculty of Nursing and Midwifery, Tehran University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6693 7120</telephone>
        <email>tehrantarasht@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Akram Sadat Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tohid Square - Nosrat Sharghi St. - Faculty of Nursing and Midwifery, Tehran University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>00 (21) 66937120</telephone>
        <email>tehrantarasht@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The baby should be in the first 24 hours after birth
Intrauterine age less than 37 weeks at birth
Stored inside the incubator
The baby's body temperature is in the range of 2.36 / 2-37 degrees Celsius
RDS score Between 5 and 8
Apgar score is five minutes, seven and more
Mother of cigarettes, alcohol or unused drugs
No severe congenital anomalies and congenital infections
The baby is not under Early Cpap</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>5 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having a secondary infection
Seizures
Consecutive apnea
Grade 3 and 4 intraventricular hemorrhage based on third day ultrasound
Registration or death of the infant before the intervention</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J80</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute respiratory distress syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: Infants who are exposed to the smell of breast milk. 3 cc of milk is taken daily from mothers to perform research; Sampling is done in the morning before breakfast to reduce the effect of odor on the milk in the mother's diet; Because the smell of food is secreted in milk 2-4 hours after consumption. Milk is stored in special plastic containers in the refrigerator. It is worth mentioning that breast milk will be used twice a day; ; Once at 8 o'clock in the morning and the next time at 12 noon, considering that the milk will be taken from the mothers only in the morning, the milk should be kept in the refrigerator for the evening shift. Prior to the intervention, the breast milk will be heated to 37 ° C by a water heater (Ben Marie).</i_keyword>
      <i_keyword>Intervention group2:To prepare formula milk as a placebo (placebo group), use dry milk for premature babies with the Bebelac brand in the section, which was prepared just before use. Prior to the intervention, the formula milk (to body temperature) will be heated to 37 ° C by a water heater (Ben Marie).</i_keyword>
      <i_keyword>Control group: Does not receive any intervention</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Respiratory distress. Timepoint: Before the intervention - four hours after the intervention and 8 hours after the intervention. Method of measurement: Respiratory Distress Assessment Questionnaire (Downs Score).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Blood oxygen saturation. Timepoint: Before intervention - 4 hours after intervention and 8 hours after intervention. Method of measurement: Pulse oximetry device.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>medical University Tehran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-02-20</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Jomhory St. 60.  No. 16 Qom Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
